[{"ID":"5378_12-2021_NCT02432196","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded. The patient has severe mitral regurgitation, which is an exclusion criterion for the clinical trial. Additionally, the patient has a history of gestational diabetes mellitus, hypertension during pregnancy, and obesity, which may also be exclusion criteria.","PROBA":0.9886728576},{"ID":"30612_65-2021_NCT01557465","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. excluded","PROBA":0.8822464198},{"ID":"35572_75-2021_NCT02730065","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nC. irrelevant","PROBA":0.9541112525},{"ID":"33729_71-2021_NCT02774668","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.8702037651},{"ID":"5443_12-2021_NCT03278574","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9727470726},{"ID":"35560_75-2021_NCT02657681","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. excluded","PROBA":0.942125313},{"ID":"11642_17-2022_NCT01874132","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9989351183},{"ID":"6816_15-2021_NCT02243007","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA: eligible","PROBA":0.9993118842},{"ID":"5318_12-2021_NCT01708265","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. Excluded","PROBA":0.9998957366},{"ID":"14106_30-2021_NCT02526719","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nC. irrelevant","PROBA":0.9999958788},{"ID":"17449_36-2021_NCT04835558","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9999847412},{"ID":"6690_15-2021_NCT01252719","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9597019404},{"ID":"17226_36-2021_NCT03082781","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded. The patient is not an older adult woman (elderly), and she does not have abnormal weight gain. She is an obese woman with a BMI of 41.54, which is outside the age and weight range of the clinical trial. Additionally, the patient has a history of trying diets and exercise to lose weight, which would make her ineligible for the study since it only includes women with abnormal weight gain.","PROBA":0.9711716991},{"ID":"6894_15-2021_NCT02984501","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA: eligible","PROBA":0.999250465},{"ID":"13974_30-2021_NCT00677469","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9994608089},{"ID":"30893_65-2021_NCT03888664","TOPIC_YEAR":2021,"RESPONSE":"$}}%C%>","PROBA":0.9999968767},{"ID":"5310_12-2021_NCT01635244","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded. The patient does not have severe aortic stenosis (AS), which is a requirement for participation in the clinical trial. The patient has mitral valve prolapse with regurgitation, which is not the same as aortic stenosis. Additionally, the patient is planned for mitral valve repair\/replacement surgery, which is not one of the interventions being studied in the clinical trial.","PROBA":0.9764644262},{"ID":"17033_36-2021_NCT01492413","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB based on the information provided, the patient is excluded from the clinical trial because she has a weight loss of 10 or more pounds in the last 3 months. This is one of the exclusion criteria listed in the trial.","PROBA":0.9928112714},{"ID":"6712_15-2021_NCT01442441","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded. The patient is not eligible for the clinical trial because the trial is focused on chronic pancreatitis, and the patient has been diagnosed with pancreatic adenocarcinoma, which is a different condition.","PROBA":0.9897409462},{"ID":"33899_71-2021_NCT04197817","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9999958351}]
